{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T04:14:07Z","timestamp":1746677647261,"version":"3.40.5"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objectives:<\/jats:title>\n            <jats:p>We aim to characterize the clinical, pathological, laboratory and imaging features of various antibody defined IIM subgroups in Indian population.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methodology:<\/jats:title>\n            <jats:p>103 patients who satisfied 2017 ACR\/ EULAR Classification criteria for IIM, and tested seropositive for myositis antibodies using Immunoblot technique were retrospectively identified. Patients were classified into following subgroups \u2013 Mi2B group, SRP group, Anti RNA Synthetase antibody group (Jo 1, PL 7, PL 12, OJ), multiple MSA, only MAA group (U1RNP, Ro 52, SS-A, SS-B, PM Scl 75, PM Scl 100). Clinical, laboratory, histopathology and imaging parameters were compared among different groups.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Ro52 (n = 31; 22.46%) was the most common autoantibody seen in our cohort followed by Mi2B (n = 26; 18.84%) and SRP (n = 20; 14.49%). Skin manifestations (<jats:italic toggle=\"yes\">p<\/jats:italic> = 0.053) and joint involvement (<jats:italic toggle=\"yes\">p<\/jats:italic> = 0.023) were seen more frequently among Mi2B and MAA sub groups. Three out of 4 patients with persisting antibody positivity on serial measurements developed clinical relapse between 2 and 3 years after the initial episode. Remaining 2 patients showed declining titres of antibodies and developed no clinical relapses during follow up period of 5 and 6 years. Among histopathology features, perifascicular atrophy was found to be more prevalent among Mi2B (55.6%) and MAA subgroups (31.3%) (<jats:italic toggle=\"yes\">p<\/jats:italic> value = 0.037). In thigh muscle MRI, Mi2B group showed a pattern of diffuse involvement of affected muscles without regional preference, with sparing of hamstring group. SRP group showed characteristic pattern of edema involving peripheral regions of Quadriceps femoris and central regions of Adductor group along with severe atrophy involving hamstring and adductor compartment muscles. ILD was seen in 27.5% of patients who underwent CT Chest. 3 patients were found to have underlying malignancy at the time of diagnosis of myositis (Mi2B = 2 and PM Scl = 1).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Classification of IIM patients based on myositis antibodies yields subgroups with certain differences in clinical, laboratory, histopathological and imaging features.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cnd.0000000000000487","type":"journal-article","created":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T17:00:50Z","timestamp":1731949250000},"page":"70-81","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Autoantibody-Based Clinicoradiopathologic Phenotyping of Idiopathic Inflammatory Myopathies: An Indian Cohort"],"prefix":"10.1097","volume":"26","author":[{"given":"Manu","family":"Santhappan Girija","sequence":"first","affiliation":[{"name":"Department of Neurology;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seena","family":"Vengalil","sequence":"additional","affiliation":[{"name":"Department of Neurology;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karthik","family":"Kulanthaivelu","sequence":"additional","affiliation":[{"name":"Department of Neuroradiology; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepak","family":"Menon","sequence":"additional","affiliation":[{"name":"Department of Neurology;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saraswati","family":"Nashi","sequence":"additional","affiliation":[{"name":"Department of Neurology;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sridhar","family":"Sreerangappa","sequence":"additional","affiliation":[{"name":"Department of Neurology;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravindu","family":"Tiwari","sequence":"additional","affiliation":[{"name":"Department of Neurology;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MM","family":"Samim","sequence":"additional","affiliation":[{"name":"Department of Neurology;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dipti","family":"Baskar","sequence":"additional","affiliation":[{"name":"Department of Neurology;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beevinahalli","family":"Nandeesh","sequence":"additional","affiliation":[{"name":"Department of Neuropathology, National Institute of Mental Health and Neurosciences, Bengaluru, India."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shilpa","family":"Rao","sequence":"additional","affiliation":[{"name":"Department of Neuropathology, National Institute of Mental Health and Neurosciences, Bengaluru, India."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Mahadevan","sequence":"additional","affiliation":[{"name":"Department of Neuropathology, National Institute of Mental Health and Neurosciences, Bengaluru, India."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atchayaram","family":"Nalini","sequence":"additional","affiliation":[{"name":"Department of Neurology;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250507","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3233\/JND-180308","article-title":"Current classification and management of inflammatory myopathies","volume":"5","author":"Schmidt","year":"2018","journal-title":"J Neuromuscul Dis"},{"key":"R2-20250507","first-page":"335","article-title":"Autoantibodies in polymyositis and dermatomyositis","volume":"15","author":"Ghirardello","year":"2013","journal-title":"Currrheumatol Rep"},{"key":"R3-20250507","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s13317-014-0060-4","article-title":"Myositis autoantibodies and clinical phenotypes","volume":"5","author":"Ghirardello","year":"2014","journal-title":"Autoimmun Highlights"},{"key":"R4-20250507","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1001\/jamaneurol.2018.2598","article-title":"Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies","volume":"75","author":"Mariampillai","year":"2018","journal-title":"JAMA Neurol"},{"key":"R5-20250507","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s42466-022-00213-9","article-title":"PET-MRI in idiopathic inflammatory myositis: a comparative study of clinical and immunological markers with imaging findings","volume":"4","author":"Girija","year":"2022","journal-title":"Neurol Res Pract"},{"key":"R6-20250507","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrrheum.2018.56","article-title":"Autoantibodies in myositis","volume":"14","author":"McHugh","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"R7-20250507","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4081\/reumatismo.2005.22","article-title":"Myositis specific and myositis associated autoantibodies in idiopathic inflammatory myopathies: a serologic study of 46 patients","volume":"57","author":"Ghirardello","year":"2011","journal-title":"Reumatismo"},{"key":"R8-20250507","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/BOR.0b013e3282f01a8c","article-title":"Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significance","volume":"19","author":"Mimori","year":"2007","journal-title":"Curr Opin Rheumatol"},{"key":"R9-20250507","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/ard.60.2.116","article-title":"Autoantibody profiles in the sera of European patients with myositis","volume":"60","author":"Brouwer","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"R10-20250507","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jaut.2019.04.001","article-title":"Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients","volume":"101","author":"Betteridge","year":"2019","journal-title":"J Autoimmun"},{"key":"R11-20250507","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10067-018-4267-z","article-title":"Myositis autoantibody profiles and their clinical associations in Greek patients with inflammatory myopathies","volume":"38","author":"Zampeli","year":"2019","journal-title":"Clin Rheumatol"},{"key":"R12-20250507","doi-asserted-by":"crossref","first-page":"552","DOI":"10.4103\/aian.AIAN_1151_20","article-title":"The association of myositis specific antibodies in patients with inflammatory myositis: preliminary data in Indian patients","volume":"24","author":"Negalur","year":"2021","journal-title":"Ann Indian Acadneurol"},{"key":"R13-20250507","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.semarthrit.2020.10.014","article-title":"Myositis-specific and myositis-associated autoantibodies in a large Indian cohort of inflammatory myositis","volume":"51","author":"Gupta","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"R14-20250507","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1007\/s10067-021-05797-2","article-title":"Myositis-specific antibodies and clinical characteristics in patients with autoimmune inflammatory myopathies: reported by the Argentine Registry of Inflammatory Myopathies of the Argentine Society of Rheumatology","volume":"40","author":"G\u00f3mez","year":"2021","journal-title":"Clin Rheumatol"},{"key":"R15-20250507","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1007\/s10067-015-2935-9","article-title":"Distinct profiles of myositis-specific autoantibodies in Chinese and Japanese patients with polymyositis\/dermatomyositis","volume":"34","author":"Chen","year":"2015","journal-title":"Clin Rheumatol"},{"key":"R16-20250507","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2016.02.017","article-title":"Testing for myositis specific autoantibodies: comparison between line blot and immunoprecipitation assays in 57 myositis sera","volume":"433","author":"Cavazzana","year":"2016","journal-title":"J Immunological Methods"},{"key":"R17-20250507","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/art.1780280711","article-title":"The association between Mi-2 antibodies and dermatomyositis","volume":"28","author":"Targoff","year":"1985","journal-title":"Arthritis Rheum"},{"key":"R18-20250507","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/08916930600622884","article-title":"Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies","volume":"39","author":"Yoshifuji","year":"2006","journal-title":"Autoimmunity"},{"key":"R19-20250507","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1136\/thx.2006.069237","article-title":"Interstitial lung disease and anti-Jo-1 antibodies: difference between acute and gradual onset","volume":"63","author":"Tillie-Leblond","year":"2008","journal-title":"Thorax"},{"key":"R20-20250507","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1136\/ard.2006.052191","article-title":"Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy","volume":"65","author":"Hengstman","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"R21-20250507","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00005792-199111000-00002","article-title":"A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups","volume":"70","author":"Love","year":"1991","journal-title":"Medicine"},{"key":"R22-20250507","doi-asserted-by":"crossref","first-page":"1019972","DOI":"10.3389\/fimmu.2022.1019972","article-title":"Anti-SRP immune-mediated necrotizing myopathy: a critical review of current concepts","volume":"13","author":"Ma","year":"2022","journal-title":"Front Immunol"},{"key":"R23-20250507","doi-asserted-by":"crossref","first-page":"e12954","DOI":"10.1111\/bpa.12954","article-title":"MRI and muscle imaging for idiopathic inflammatory myopathies","volume":"31","author":"Malartre","year":"2021","journal-title":"Brain Pathol"},{"key":"R24-20250507","doi-asserted-by":"crossref","first-page":"e000850","DOI":"10.1136\/rmdopen-2018-000850","article-title":"MRI of skeletal muscles in patients with idiopathic inflammatory myopathies: characteristic findings and diagnostic performance in dermatomyositis","volume":"5","author":"Ukichi","year":"2019","journal-title":"RMD Open"},{"key":"R25-20250507","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/annrheumdis-2016-210198","article-title":"Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity","volume":"76","author":"Pinal-Fernandez","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R26-20250507","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.rmed.2016.10.019","article-title":"Comprehensive assessment of myositis-specific autoantibodies in polymyositis\/dermatomyositis-associated interstitial lung disease","volume":"121","author":"Hozumi","year":"2016","journal-title":"Respir Med"},{"key":"R27-20250507","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2152\/jmi.65.251","article-title":"Clinical characteristics of dermatomyosits\/polymyositis associated interstitial lung disease according to the autoantibody","volume":"65","author":"Kishaba","year":"2018","journal-title":"J Med Invest"},{"key":"R28-20250507","doi-asserted-by":"crossref","first-page":"5483","DOI":"10.1093\/rheumatology\/keab616","article-title":"Corrigendum to: a systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies","volume":"60","author":"Oldroyd","year":"2021","journal-title":"Rheumatology"}],"container-title":["Journal of Clinical Neuromuscular Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CND.0000000000000487","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T21:02:18Z","timestamp":1746651738000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CND.0000000000000487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/cnd.0000000000000487","relation":{},"ISSN":["1522-0443","1537-1611"],"issn-type":[{"type":"print","value":"1522-0443"},{"type":"electronic","value":"1537-1611"}],"subject":[],"published":{"date-parts":[[2024,12]]}}}